GEMIN4 and myeloid sarcoma: The GG AGO1 rs636832 and AA GEMIN4 rs636832 genotypes were associated with an increased risk of MS (OR = 1.8218, 95% CI, 1.0336–3.2108; p = 0.0350 and OR = 2.2588, 95% CI, 1.3940–3.6602; p = 0.0007 respectively), while the GAAGO1 rs636832 and GA GEMIN4 rs636832 genotypes were associated with a lower risk of developing MS (OR = 0.5025; 95% CI; 0.2778–0.9089; p = 0.0202 and OR = 0.4479; 95% CI; 0.2962–0.6775; p = 0.0001 respectively).